The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Women with polycystic ovary syndrome (PCOS) present with vascular abnormalities, including elevated markers of endothelial dysfunction. There is limited evidence for the effect of lifestyle modification and weight loss on these markers. The aim of this study was to determine if 20 weeks of a high-protein energy-restricted diet with or without exercise in women with PCOS could improve endothelial function. METHODS: This is a secondary analysis of a subset of 50 overweight/obese women with PCOS (age: 30.3 ± 6.3 years; BMI: 36.5 ± 5.7 kg/m(2)) from a previous study. Participants were randomly assigned by computer generation to one of three 20-week interventions: diet only (DO; n = 14, ≈ 6000 kJ/day), diet and aerobic exercise (DA; n = 16, ≈ 6000 kJ/day and five walking sessions/week) and diet and combined aerobic-resistance exercise (DC; n = 20, ≈ 6000 kJ/day, three walking and two strength sessions/week). At Weeks 0 and 20, weight, markers of endothelial function [vascular cell adhesion molecule-1 (sVCAM-1), inter-cellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1) and asymmetric dimethylarginine (ADMA)], insulin resistance and hormonal profile were assessed. RESULTS: All three treatments resulted in significant weight loss (DO 7.9 ± 1.2%, DA 11.0 ± 1.6%, DC 8.8 ± 1.1; P < 0.001 for time; P = 0.6 time × treatment). sVCAM-1, sICAM-1 and PAI-1 levels decreased with weight loss (P≤ 0.01), with no differences between treatments (P ≥ 0.4). ADMA levels did not change significantly (P = 0.06). Testosterone, sex hormone-binding globulin and the free androgen index (FAI) and insulin resistance also improved (P < 0.001) with no differences between treatments (P ≥ 0.2). Reductions in sVCAM-1 were correlated to reductions in testosterone (r = 0.32, P = 0.03) and FAI (r = 0.33, P = 0.02) as well as weight loss (r= 0.44, P = 0.002). Weight loss was also associated with reductions in sICAM-1 (r= 0.37, P = 0.008). CONCLUSIONS: Exercise training provided no additional benefit to following a high-protein, hypocaloric diet on markers of endothelial function in overweight/obese women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisløff, U., Støylen, A., Loennechen, J. P., Bruvold, M., Rognmo, Ø., Haram, P. M., Tjønna, A. E., Helgerud, J., Slørdahl, S. A., Lee, S. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675041 · Cited by 1,996
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Self-citationNorman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · cited 2×
“PCOS also increases the prevalence and risk of cardiovascular disturbances including insulin resistance, hypertension and dyslipidaemia (Norman et al., 2007; Wild et al., 2010), which impact negatively on the long-term health and leads to the development of cardiovascular disease (CVD).”
BackgroundSelf-citationThögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562 · cited 9×
“, 2010) and have been shown to predict the development of CVD (Thögersen et al., 1998; Blankenberg et al., 2001; Valkonen et al., 2001).”
BackgroundInfluentialEffective exercise modality to reduce insulin resistance in women with type 2 diabetes
Cuff, D. J., Meneilly, G. S., Martin, A., Ignaszewski, A., Tildesley, H. D., & Frohlich, J. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.2977 · Cited by 545
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020815 · Cited by 530
Self-citationMoran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.018 · Cited by 444
Self-citationHolte, J., Bergh, T., Berne, C., Wide, L., & Lithell, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673399 · Cited by 435
Thomson, R. L., Buckley, J. D., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0751 · Cited by 277 · cited 7×
“The data analysed for this study were obtained from a subset of women who completed a large randomized controlled trial that concurrently investigated the effects of a hypocaloric diet with and without exercise training on body composition, metabolic and reproductive outcomes in overweight and obese women that has bee…”
BackgroundMethodInfluentialSelf-citationOverweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0011 · Cited by 273 · cited 2×
“and endothelial function (Meyer et al., 2005).”
ResultPalomba, S., Giallauria, F., Falbo, A., Russo, T., Oppedisano, R., Tolino, A., Colao, A., Vigorito, C., Zullo, F., & Orio, F. (2008) · Human Reproduction · doi:10.1093/humrep/dem391 · Cited by 235
Meckling, K. A., O’Sullivan, C., & Saari, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031606 · Cited by 233 · cited 16×
“Several pharmacological studies in women with PCOS have also shown the beneficial effects of insulin sensitizers including metformin and rosiglitazone and oral contraceptive treatment on endothelial function (by reductions in PAI-1 and VCAM levels) after 3–12 months of treatment (DiamantiKandarakis et al., 2006a,b; Te…”
ResultInfluentialVigorito, C., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Lucci, R., De Lorenzo, A., Tafuri, D., Lombardi, G., Colao, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2794 · Cited by 211
Zoppini, G., Targher, G., Zamboni, C., Venturi, C., Cacciatori, V., Moghetti, P., & Muggeo, M. (2006) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.004 · Cited by 173 · cited 1×
“…training on endothelial function in both healthy and diseased populations, some specifically with reductions in sICAM-1 (Adamopoulos et al., 2001; Zoppini et al., 2006; Saetre et al., 2011) and sVCAM-1 (Adamopoulos et al., 2001; Rankovic et al., 2009), ADMA (Richter et al., 2005; Schlager et…”
BackgroundAndersen, P., Seljeflot, I., Abdelnoor, M., Arnesen, H., Dale, P. O., Løvik, A., & Birkeland, K. (1995) · Metabolism · doi:10.1016/0026-0495(95)90118-3 · Cited by 156
Teede, H. J., Meyer, C., Hutchison, S. K., Zoungas, S., McGrath, B. P., & Moran, L. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.034 · Cited by 68
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59 · cited 9×
“…dysfunction and insulin resistance (Paradisi et al., 2001; Kravariti et al., 2005; Diamanti-Kandarakis et al., 2006a,b; Heutling et al., 2008; Moran et al., 2009a, 2011), hyperandrogenism (Paradisi et al., 2001; Kravariti et al., 2005; Diamanti-Kandarakis et al., 2006a,b; Heutling et al.,…”
BackgroundResultInfluentialCakir, E., Ozcan, O., Yaman, H., Akgul, E. O., Bilgi, C., Erbil, M. K., & Yesilova, Z. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2045 · Cited by 28 · cited 1×
“It has been previously demonstrated that increasing testosterone levels reduce ADMA levels; however, this occurred following testosterone administration in males in a hypogonadal state (Cakir et al., 2005; Leifke et al., 2008).”
BackgroundLeifke, E., Kinzel, M., Tsikas, D., Gooren, L., Frölich, J., & Brabant, G. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2007-1004529 · Cited by 18 · cited 1×
“It has been previously demonstrated that increasing testosterone levels reduce ADMA levels; however, this occurred following testosterone administration in males in a hypogonadal state (Cakir et al., 2005; Leifke et al., 2008).”
Background
Research works printed but not linked: 44
- Adamopoulos, 2001, European Heart Journal, 22, 791, 10.1053/euhj.2000.2285 · DOI · Paper page
- Blankenberg, 2001, Circulation, 104, 1336, 10.1161/hc3701.095949 · DOI · Paper page
- Carey, 1996, Diabetes, 45, 633, 10.2337/diab.45.5.633 · DOI · Paper page
- Carmassi, 2005, Thrombosis research, 116, 207, 10.1016/j.thromres.2004.11.026 · DOI
- 2006, The American journal of medicine, 119, 356.e351
- 2008, 196, 958
- Diamanti-Kandarakis, 2005, European Journal of Endocrinology, 152, 749, 10.1530/eje.1.01910 · DOI · Paper page
- Diamanti-Kandarakis, 2006, European journal of clinical investigation, 36, 691, 10.1111/j.1365-2362.2006.01712.x · DOI · Paper page
- 2006, Human Reproduction, 21, 1426, 10.1093/humrep/del003 · DOI · Paper page
- Giallauria, 2008, Clinical endocrinology, 69, 792, 10.1111/j.1365-2265.2008.03305.x · DOI · Paper page
- Hamdy, 2003, Diabetes Care, 26, 2119, 10.2337/diacare.26.7.2119 · DOI · Paper page
- 2008, Journal of Clinical Endocrinology & Metabolism, 93, 82, 10.1210/jc.2007-0842 · DOI · Paper page
- Holte, 1995, Journal of Clinical Endocrinology & Metabolism, 80, 2586, 10.1210/jc.80.9.2586 · doi:10.1210/jc.80.9.2586 · Paper page
- 2008, CENT EUR J MED, 3, 257, 10.2478/s11536-008-0044-8 · DOI
- Jahangard, 2009, 64, 223, 10.1016/j.maturitas.2009.09.003 · doi:10.1016/j.maturitas.2009.09.003
- Keogh, 2008, The American Journal of Clinical Nutrition, 87, 567, 10.1093/ajcn/87.3.567 · DOI · Paper page
- 2005, Journal of Clinical Endocrinology & Metabolism, 90, 5088, 10.1210/jc.2005-0151 · DOI · Paper page
- McCrohon, 1999, Circulation, 99, 2317, 10.1161/01.CIR.99.17.2317 · DOI · Paper page
- Mohamadin, 2010, Annals of Saudi medicine, 30, 278, 10.4103/0256-4947.65255 · DOI
- Moran, 2006, Reproductive biomedicine online, 12, 569, 10.1016/S1472-6483(10)61182-0 · DOI
- 2011, Human Reproduction, 26, 192
- Mukherjee, 2002, PNAS, 99, 4055, 10.1073/pnas.052703199 · DOI · Paper page
- Murakami, 2007, Thrombosis research, 119, 45, 10.1016/j.thromres.2005.12.013 · DOI
- 2007, 31, 996, 10.1038/sj.ijo.0803534 · DOI · Paper page
- Orio, 2004, Journal of Clinical Endocrinology & Metabolism, 89, 4588, 10.1210/jc.2003-031867 · DOI · Paper page
- 2005, Journal of Clinical Endocrinology & Metabolism, 90, 6072, 10.1210/jc.2005-0965 · DOI · Paper page
- Ozgurtas, 2008, 200, 336, 10.1016/j.atherosclerosis.2007.12.054 · DOI
- 2007, Human Reproduction, 23, 642
- Paradisi, 2001, Circulation, 103, 1410, 10.1161/01.CIR.103.10.1410 · DOI · Paper page
- Park, 2003, Journal of physiological anthropology and applied human science, 22, 129, 10.2114/jpa.22.129 · DOI · Paper page
- Rajendran, 2009, 204, 509, 10.1016/j.atherosclerosis.2008.09.010 · DOI
- Rankovic, 2009, Vojnosanitetski pregled. Military-medical and pharmaceutical review, 66, 44, 10.2298/VSP0901044R · DOI · Paper page
- Rector, 2006, 31, 512, 10.1139/h06-040 · DOI
- Richter, 2005, Thrombosis and haemostasis, 94, 1306
- 2011, 62, 301, 10.1177/0003319710385338 · DOI · Paper page
- Schjerve, 2008, Clinical science (London, England : 1979), 115, 283, 10.1042/CS20070332 · DOI · Paper page
- Schlager, 2011, 217, 240, 10.1016/j.atherosclerosis.2011.03.018 · DOI
- Tarkun, 2004, Journal of Clinical Endocrinology & Metabolism, 89, 5592, 10.1210/jc.2004-0751 · DOI · Paper page
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus, 2004, Human Reproduction, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
- 2011, Human Reproduction Update, 17, 741, 10.1093/humupd/dmr025 · DOI · Paper page
- 2011, EUR J CARDIOVASC PREV REHABIL, 18, 594, 10.1177/1741826710397099 · DOI
- Walther, 2004, Exercise and sport sciences reviews, 32, 129, 10.1097/00003677-200410000-00002 · DOI · Paper page
- Wegge, 2004, Metabolism: clinical and experimental, 53, 377, 10.1016/j.metabol.2003.10.016 · DOI
- Zhang, 2002, Methods and findings in experimental and clinical pharmacology, 24, 125, 10.1358/mf.2002.24.3.802295 · doi:10.1358/mf.2002.24.3.802295
Cited by
Ennour-Idrissi, K., Maunsell, E., & Diorio, C. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0647-3 · Cited by 193
Kite, C., Lahart, I. M., Afzal, I., Broom, D. R., Randeva, H., Kyrou, I., & Brown, J. E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0962-3 · Cited by 155
Haqq, L., McFarlane, J., Dieberg, G., & Smart, N. (2014) · Endocrine Connections · doi:10.1530/ec-14-0010 · Cited by 101
Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., Ajjan, R. A., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0005-6 · Cited by 74
“Weight loss has been found to reduce many CV risk markers in PCOS including inflammation, and insulin resistance (IR) [8].”
BackgroundResistance exercise impacts lean muscle mass in women with polycystic ovary syndrome
KOGURE, G. S., MIRANDA-FURTADO, C. L., SILVA, R. C., MELO, A. S., FERRIANI, R. A., DE SÁ, M. F. S., & REIS, R. M. D. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000822 · Cited by 68
Metadata
- Authors
- Thomson, R. L., Brinkworth, G. D., Noakes, M., Clifton, P. M., Norman, R. J., & Buckley, J. D.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-02
- Volume
- 27
- Issue
- 7
- Pages
- 2169-2176
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2072905172
- Cited by
- 55
- References
- 21
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.